Antimicrobial Profile and Prevalence of Salmonella Species from Blood Culture in A Tertiary Care Hospital


  • Charu Jain MD Microbiology, Assistant Professor, Department of Microbiology, ESIC Medical College and Hospital, Faridabad, Haryana, India.
  • Nikita PhD Medical Microbiology, Department of Microbiology, SGT University, Budhera, Gurugram, Haryana, India.



Enteric fever , Nalidixic Acid Resistant, Fluoroquinolones, Salmonella


Background & Aim: Enteric fever is a major public health concern around the world and endemic in low- and middle-income countries like, India. Typically, it spreads through contaminated food or water. Salmonella Typhi proliferate and spread throughout the bloodstream seeding multiple organs in the body. Incidence data of culture confirmed Typhoid cases is approximately 377per 100000 population with an approximate case fatality rate of 1% in India. The management of cases are hampered due to emerging the drug resistance of isolates because of rampant and misuse of antibiotics. This study investigates to analyse the current pattern of antibiotic susceptibility among Salmonella isolates from cases of enteric fever seen at ESIC Medical College & Hospital, Faridabad.

Material & Methods: This is a retrospective, cross-sectional study. Blood cultures from patients with suspected enteric fever from Jan 2017 to Dec 2019 were included. The blood cultures were processed using the BacT/Alert automated blood culture system.

Results: During the study period, a total of 4064 blood culture specimens were received from the patients suspected for fever. Out of a total of 2717 culture positive samples, 373 (13.73%) were found positive for the growth of Salmonella enterica [Salmonella typhi 87.13% (325/373), Salmonella paratyphi A (12.86%)], confirming the enteric fever.

Conclusion: Treatment with appropriate antimicrobial drugs is crucial for patients with typhoidal infections and the antimicrobial susceptibility of such isolates must be reported as soon as possible.


Download data is not yet available.


Typhoid. [Internet] World Health Organization. 2018. Jan 31, [2021 Mar 14;]. sheets/detail/typhoid Available from

Manandhar R, Raghubanshi BR, Neupane S, Lama R. Prevalence of Enteric Fever Pathogens Isolated from Blood Culture at a Tertiary Care Centre. JNMA: Journal of the Nepal Medical Association. 2021 Mar;59(235):256.

CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.

Mogasale V, Ramani E, Mogasale VV, Park J. What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature reviews. Annals of clinical microbiology and antimicrobials. 2016 Dec;15(1):1-8.

Misra R, Prasad KN. Antimicrobial susceptibility to azithromycin among salmonella enterica typhi and Paratyphi A isolates from India. J Med Microbiol 2016; 65:1536 9.

Bhumbla U, Chaturvedi P, Jain S. Prevalence of Salmonella typhi in among febrile patients in a tertiary care hospital of South West Rajasthan. Journal of Family Medicine and Primary Care. 2022 Jun 1;11(6):2852-5.

Patil N, Mule P. Sensitivity pattern of Salmonella typhi and paratyphi a isolate to chloramphenicol and other anti typhoid drugs: An in vitro study. Infect Drug Resist 2019; 12:3217 25.

Mackie & McCartney Practical Medical Microbiology;14th Edition 2016 By JG Collee.

John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS neglected tropical diseases. 2016 Apr 15;10(4): e0004616.

Veeraraghavan B, Pragasam AK, Ray P, Kapil A, Nagaraj S, Perumal SP, Saigal K, Thomas M, Gupta M, Rongsen-Chandola T, Jinka DR. Evaluation of antimicrobial susceptibility profile in Salmonella typhi and Salmonella paratyphi A: presenting the current scenario in India and strategy for future management. The Journal of Infectious Diseases. 2021 Nov 15;224(Supplement_5): S502-16.

Barkume C, Date K, Saha SK, et al. Phase I of the surveillance for enteric fever in Asia Project (SEAP): an overview and lessons learned. J Infect Dis 2018; 218:188–94.

Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: antimicrobial resistance and implications for vaccine policy. PLoS Negl Trop Dis 2018; 12: e0006408.

Khan S, Kurup P, Vinod V, Biswas R, Pillai GK, Kumar A. Reconsidering azithromycin disc diffusion interpretive criteria for salmonellae in view of azithromycin MIC creep among typhoidal and nontyphoidal salmonella. J Lab Physicians 2019; 11:39–44.

Kumar Y, Sharma A, Mani KR (2009) High Level of Resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India. J Infect Dev Ctries 3:467–469. doi: 10.3855/jidc.419.

Rodrigues C, Mehta A, Joshi VR (1999) Nalidixic acid-resistant Salmonella Typhi in Mumbai. Natl Med J India12:88.

Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella Typhi.BMC Infectious Diseases5:37.

Kapil A, Das B (2002) Nalidixic acid susceptibility to screen ciprofloxacin resistance in SalmonellaTyphi. Indian J Med Res115: 49-54.




How to Cite

Jain, C. ., & Nikita. (2023). Antimicrobial Profile and Prevalence of Salmonella Species from Blood Culture in A Tertiary Care Hospital. Medical and Health Science Journal, 7(02), 1–6.